Human Normal Immunoglobulin solution for Infusion is employed to enhance the natural immune system, reducing the susceptibility to infections in individuals with compromised immune function. Derived from healthy human blood containing elevated levels of specific defensive substances (antibodies), it aids in the combat against infections.

Demonstrating efficacy in preventing infections within the first 100 days post-transplant in bone marrow recipients aged over 20, Human Normal Immunoglobulin solution for Infusion is utilized for individuals with severely impaired antibody-forming capacity, heightening their vulnerability to infections. By supplying antibodies not naturally produced by the body, this solution enables the individual to better combat infections. This therapeutic approach is applicable to both children and adults and is administered through injections. Following the administration, the doctor monitors the individual for a period to assess any potential side effects.